Centreville, VA, United States of America

Jason D Bannan

This inventor holds 2 USPTO granted patents. Top assignee: The Rockefeller University. Active years: 2000-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason D Bannan. Retrieved from https://idiyas.com/inventor/jason-d-bannan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Thompson Station, TN (US) (2000)
  • Centreville, VA (US) (2006)

Company Filing History:


Years Active: 2000-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jason D Bannan: Innovator in Toxic Shock Syndrome Research

Introduction

Jason D Bannan is a notable inventor based in Centreville, VA (US). He has made significant contributions to the field of medical research, particularly in the area of toxic shock syndrome and septic shock. With a total of 2 patents, his work focuses on developing innovative solutions to combat the effects of bacterial infections.

Latest Patents

Bannan's latest patents include groundbreaking inventions related to peptides that are useful for reducing symptoms of toxic shock syndrome and septic shock. The first patent describes compositions and methods that provide protection against, or reduce the severity of, toxic shock and septic shock from bacterial infections. This invention specifically relates to peptides derived from homologous sequences of staphylococcal and streptococcal toxins, which may be polymeric, along with carrier-conjugates thereof. Additionally, it covers serum antibodies induced by these peptides and their use in preventing, treating, or protecting against the toxic effects of various staphylococcal and streptococcal toxins. The invention also includes diagnostic assays and kits designed to detect the presence of these toxins or antibodies, as well as isolated and purified nucleic acids encoding the peptides and transformed host cells containing those nucleic acids.

The second patent focuses on eliciting an immunogenic response in mammals to provide protection against toxic shock from bacterial infections. Similar to the first, it involves peptides derived from homologous sequences of staphylococcal and streptococcal toxins and their use in inducing serum antibodies. This invention also encompasses diagnostic assays and kits for detecting the presence of toxins or antibodies, along with isolated and purified nucleic acids and transformed host cells.

Career Highlights

Jason D Bannan is affiliated with The Rockefeller University, where he continues to advance his research in the field of immunology and infectious diseases. His work has garnered attention for its potential to significantly impact the treatment and prevention of severe bacterial infections.

Collaborations

Bannan has collaborated with esteemed colleagues such as John B Zabriskie and Kumar Visvanathan, contributing to a rich environment of innovation and research.

Conclusion

Jason D Bannan's contributions to the field of toxic shock syndrome research highlight his dedication to improving medical outcomes through innovative inventions. His work not only addresses critical health challenges but also paves the way for future

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…